Home Aminos 3-[2-(tert-butylamino)-1-hydroxyethyl]-5-[(dimethylcarbamoyl)oxy]phenyl N,N-dimethylcarbamate hydrochloride

3-[2-(tert-butylamino)-1-hydroxyethyl]-5-[(dimethylcarbamoyl)oxy]phenyl N,N-dimethylcarbamate hydrochloride

CAS No.:
81732-46-9
Catalog Number:
AG003NYI
Molecular Formula:
C18H30ClN3O5
Molecular Weight:
403.9009
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5mg
98%(HPLC)
In Stock USA
United States
$60
- +
250mg
98%
In Stock USA
United States
$63
- +
1g
98%
In Stock USA
United States
$132
- +
5g
98%
In Stock USA
United States
$469
- +
10g
98%
In Stock USA
United States
$750
- +
25g
98%
In Stock USA
United States
$1500
- +
Product Description
Catalog Number:
AG003NYI
Chemical Name:
3-[2-(tert-butylamino)-1-hydroxyethyl]-5-[(dimethylcarbamoyl)oxy]phenyl N,N-dimethylcarbamate hydrochloride
CAS Number:
81732-46-9
Molecular Formula:
C18H30ClN3O5
Molecular Weight:
403.9009
MDL Number:
MFCD03427293
IUPAC Name:
[3-[2-(tert-butylamino)-1-hydroxyethyl]-5-(dimethylcarbamoyloxy)phenyl] N,N-dimethylcarbamate;hydrochloride
InChI:
InChI=1S/C18H29N3O5.ClH/c1-18(2,3)19-11-15(22)12-8-13(25-16(23)20(4)5)10-14(9-12)26-17(24)21(6)7;/h8-10,15,19,22H,11H2,1-7H3;1H
InChI Key:
LBARATORRVNNQM-UHFFFAOYSA-N
SMILES:
O=C(N(C)C)Oc1cc(cc(c1)OC(=O)N(C)C)C(CNC(C)(C)C)O.Cl
NSC Number:
758916
Properties
Complexity:
446  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
403.187g/mol
Formal Charge:
0
Heavy Atom Count:
27  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
403.904g/mol
Monoisotopic Mass:
403.187g/mol
Rotatable Bond Count:
8  
Topological Polar Surface Area:
91.3A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
Literature
Title Journal
Design and mechanism of on-off pulsed drug release using nonenteric polymeric systems via pH modulation. AAPS PharmSciTech 20110301
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Effects of bambuterol and terbutaline on isolated rat's tracheal smooth muscle. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 20100801
Simultaneous analysis of bambuterol and its active metabolite terbutaline enantiomers in rat plasma by chiral liquid chromatography-tandem mass spectrometry. Journal of pharmaceutical and biomedical analysis 20100605
Influence of differential expression of acetylcholinesterase in brain and muscle on respiration. Respiratory physiology & neurobiology 20090101
Stereoselective inhibition of human, mouse, and horse cholinesterases by bambuterol enantiomers. Chemico-biological interactions 20080925
Highly enantioselective synthesis, crystal structure, and circular dichroism spectroscopy of (R)-bambuterol hydrochloride. Chirality 20080701
Amino acid residues involved in stereoselective inhibition of cholinesterases with bambuterol. Archives of biochemistry and biophysics 20080301
Simultaneous estimation of Montelukast sodium and Bambuterol hydrochloride in tablets by spectrophotometry. Hindustan antibiotics bulletin 20070201
Preparative HPLC separation of bambuterol enantiomers and stereoselective inhibition of human cholinesterases. Analytical and bioanalytical chemistry 20060801
Irrational combination of montelukast and bambuterol for management of childhood asthma. Indian pediatrics 20060801
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Structure-inhibition relationships in the interaction of butyrylcholinesterase with bambuterol, haloxon and their leaving groups. Chemico-biological interactions 20051215
Quantification of bambuterol hydrochloride in a formulated product using solid-state NMR. Journal of pharmaceutical and biomedical analysis 20050810
Development and validation of HPLC methods for the enantioselective analysis of bambuterol and albuterol. Journal of pharmaceutical and biomedical analysis 20050104
Effects of acetylcholinesterase and butyrylcholinesterase inhibition on breathing in mice adapted or not to reduced acetylcholinesterase. Pharmacology, biochemistry, and behavior 20050101
Interaction of human butyrylcholinesterase variants with bambuterol and terbutaline. Journal of enzyme inhibition and medicinal chemistry 20040401
[Study on bioequivalence of domestic bambuterol capsules and imported tablets by high performance capillary zone electrophoresis]. Yao xue xue bao = Acta pharmaceutica Sinica 20031201
Effect of terbutaline and bambuterol on immediate-type allergic skin responses and mediator release in human skin. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20030901
Respiratory survival mechanisms in acetylcholinesterase knockout mouse. The European journal of neuroscience 20030901
Clinical-pharmacokinetic aspects of prolonged effect duration as illustrated by beta2-agonists. European journal of clinical pharmacology 20020701
[Determination of bambuterol in human plasma by liquid chromatography-electrospray tandem mass spectrometry: application to pharmacokinetic study]. Yao xue xue bao = Acta pharmaceutica Sinica 20011001
[Rapid analysis of terbutaline by combined solid phase extraction/liquid chromatography tandem mass spectrometry]. Yao xue xue bao = Acta pharmaceutica Sinica 20010901
[Bioequivalence of bambuteral and its metabolites terbutaline after oral bambuteral tablet in healthy volunteers by HPLC/MS]. Yao xue xue bao = Acta pharmaceutica Sinica 20010501
Age- and gender-specific asthma death rates in patients taking long-acting beta2-agonists: prescription event monitoring pharmacosurveillance studies. Drug safety 20010101
Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease. European journal of clinical pharmacology 19990101
Can oral beta2 agonists cause heart failure? Lancet (London, England) 19981003
Risk of non-fatal cardiac failure and ischaemic heart disease with long acting beta 2 agonists. Thorax 19980701
Therapeutic equivalence between bambuterol, 10 mg once daily, and terbutaline controlled release, 5 mg twice daily, in mild to moderate asthma. The European respiratory journal 19931101
Tremor in healthy volunteers after bambuterol and terbutaline CR-tablets. European journal of clinical pharmacology 19930101
Properties